Advanced

Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer.

Olofsson, Sven-Erik LU ; Nodin, Björn LU ; Gaber, Alexander LU ; Eberhard, Jakob LU ; Uhlén, Mathias; Jirström, Karin LU and Jerkeman, Mats LU (2015) In PLoS ONE 10(3).
Abstract
Expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate with favourable clinicopathological parameters and prognosis in several cancer diseases. The aim of this study was to examine the expression and prognostic ability of RBM3 in patients with testicular non-seminomatous germ cell tumours (NSGCT).
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
PLoS ONE
volume
10
issue
3
publisher
Public Library of Science
external identifiers
  • pmid:25811459
  • wos:000356353700092
  • scopus:84926366456
ISSN
1932-6203
DOI
10.1371/journal.pone.0121300
language
English
LU publication?
yes
id
c630951d-974b-4ff4-8563-a94986836f0c (old id 5257617)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25811459?dopt=Abstract
date added to LUP
2015-04-04 17:33:04
date last changed
2017-08-27 04:28:57
@article{c630951d-974b-4ff4-8563-a94986836f0c,
  abstract     = {Expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate with favourable clinicopathological parameters and prognosis in several cancer diseases. The aim of this study was to examine the expression and prognostic ability of RBM3 in patients with testicular non-seminomatous germ cell tumours (NSGCT).},
  articleno    = {e0121300},
  author       = {Olofsson, Sven-Erik and Nodin, Björn and Gaber, Alexander and Eberhard, Jakob and Uhlén, Mathias and Jirström, Karin and Jerkeman, Mats},
  issn         = {1932-6203},
  language     = {eng},
  number       = {3},
  publisher    = {Public Library of Science},
  series       = {PLoS ONE},
  title        = {Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer.},
  url          = {http://dx.doi.org/10.1371/journal.pone.0121300},
  volume       = {10},
  year         = {2015},
}